Emerita Resources Stock
€0.26
Your prediction
Emerita Resources Stock
Pros and Cons of Emerita Resources in the next few years
Pros
Cons
Performance of Emerita Resources vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emerita Resources | - | -0.769% | -6.522% | -53.091% | -31.016% | 72.000% | - |
| Dermapharm Holding SE | -1.110% | -1.252% | -5.821% | -29.827% | -25.974% | -57.365% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance, the financials of Emerita Resources, a holding company in the US, reveal a mixed picture. There are noticeable improvements in certain aspects, while some areas exhibit concerning trends. It is essential to delve deeper into the company's financial statements to identify the strengths and weaknesses based on the provided data.
Rapid growth in total assets: Emerita Resources has exhibited a significant increase in total assets over the past years. Comparing the yearly balance sheets from 2020 to 2022, total assets have jumped from CAD 1,105,001 to CAD 22,620,023. This growth indicates a successful expansion of the company's resources and capabilities.
Decrease in total liabilities: The company's total liabilities have dropped between 2020 and 2021 while slightly increasing in 2022. Reducing liabilities is a positive sign, demonstrating effective management of financial obligations and ultimately helping the company to attract investors.